Biotech · Private company
Albireo
Track this companyFree. Adds Albireo to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- A4250 (odevixibat)Phase 3 · PFIC1ClinicalTrials.gov · fetched Nov 12, 2026
- OdevixibatPhase 3 · Alagille SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ElobixibatPhase 2 · NAFLDClinicalTrials.gov · fetched Nov 12, 2026
- A4250Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- OdevixibatProgressive Familial Intrahepatic CholestasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Efficacy and Safety of Odevixibat in Patients With Alagille SyndromePHASE3 · COMPLETED · started Mar 19, 2021ClinicalTrials.gov NCT04674761 · fetched Nov 12, 2026
- A Phase 2 Study of Elobixibat in Adults With NAFLD or NASHPHASE2 · COMPLETED · started Jun 6, 2019ClinicalTrials.gov NCT04006145 · fetched Nov 12, 2026
- Study of A4250 in Healthy Volunteers Under Fasting, Fed and Sprinkled ConditionsPHASE1 · COMPLETED · started Jul 5, 2018ClinicalTrials.gov NCT03608319 · fetched Nov 12, 2026
- This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2PHASE3 · COMPLETED · started May 16, 2018ClinicalTrials.gov NCT03566238 · fetched Nov 12, 2026
- Odevixibat for the Treatment of Progressive Familial Intrahepatic CholestasisNO_LONGER_AVAILABLEClinicalTrials.gov NCT04483531 · fetched Nov 12, 2026